Yearender: Top 5 healthcare stocks that grabbed limelight in 2021

Follow us on Google News:
 Yearender: Top 5 healthcare stocks that grabbed limelight in 2021
Image source: PopTika,Shutterstock

Highlights

  • UnitedHealth Group Incorporated (NYSE: UNH) will release its Q4 and fiscal 2021 results on Jan 19, 2022.

  • The FDA authorized the emergency use of Pfizer's Paxlovid pill.

  • Abbott Laboratories (NYSE: ABT) revenue surged over 23% YoY in Q3, FY21.

Global healthcare spending touched more than US$8.3 trillion, of which over US$3.5 trillion were spent in the US alone in 2021, accelerated by pandemic-driven demand.

This exponential growth drew a lot of attention from investors looking to capitalize on the growing demand for healthcare needs.

Here we explore the top five healthcare stocks that remained in the limelight in 2021.

Also Read: Why did Crocs (CROX) stock crash on Thursday?

UnitedHealth Group Incorporated (NYSE: UNH)

UnitedHealth is a diversified healthcare and insurance company based in Minnetonka, Minnesota, and offers a range of services to customers.


The shares of the company traded at US$497.42 at 2:42 pm ET on Dec 23, up 0.67% from their previous close. Its stock rose by 41.38% YTD.

It has a market cap of US$468.01 billion, a P/E ratio of 30.83, and a forward P/E one year of 26.23. Its EPS is US$16.12. The 52-week highest and lowest stock prices were US$496.96 and US$320.35, respectively. Its trading volume was 1,687,590 on Dec 22.

The company will release its fourth quarter and fiscal 2021 results on Jan 19, 2022.

In Q3 of FY21, its revenue increased by 11% YoY to US$72.3 billion. Its net earnings were US$4.19 billion, or US$4.28 per diluted share, against US$3.25 billion, or US$3.30 per diluted share in Q3 of FY20.

Also Read: Why Nikola (NKLA) stock roared 18% higher today?

Healthcare to stocks to explore in 2021.

Source: Pixabay

Also Read: How to buy Loopring (LRC) token?

Novo Nordisk A/S (NYSE: NVO)

Novo Nordisk is a global healthcare firm based in Denmark and specializes in diabetes care. It also manufactures various other pharmaceutical products.

The stock was priced at US$108.52 at 2:49 pm ET on Dec 23, down 1.26% from its previous close. The NVO stock rose 53.86% YTD.

Its market cap is US$247.44 billion, the P/E ratio is 33.82, and the forward P/E one year is 33.61. Its EPS is US$3.21. The stock saw the highest price of US$117.35 and the lowest price of US$66.59 in the last 52 weeks. Its share volume on Dec 22 was 1,824,880.

The company's net sales rose 15% YoY to DKK 35.62 billion (US$5.43 billion) in Q3, FY21. Its net profit came in at DKK12.11 billion (US$1.85 billion), compared to DKK10.29 billion in Q3, FY20. (DKK is Danish Krone).

Also Read: Verasity (VRA) token flies on Brightcove partnership – How to buy

Pfizer, Inc. (NYSE: PFE)

Pfizer is a pharmaceutical and biotechnology company based in New York. It manufactures biopharmaceutical products and distributes them globally.

Its shares traded at US$58.73 at 3:02 pm ET on Dec 23, down 1.38% from their previous close. Its stock value rose 61.78% YTD.

It has a market cap of US$329.90 billion, a P/E ratio of 17.49, and a forward P/E one year of 14.14. Its EPS is US$3.36. The 52-week highest and lowest stock prices were US$61.71 and US$33.36, respectively. Its trading volume was 62,594,920 on Dec 22.

Also Read: Blackstone Products (BLKS) to go public via SPAC – know details

On Dec 22, the company announced receiving FDA’s emergency use authorization for Paxlovid pill for treating mild-to-moderate Covid-19 infections.

The company's revenue increased by 134% YoY to US$24.09 billion in Q3, FY21. Its net income came in at US$8.14 billion compared to US$1.46 billion in Q3, FY20.

The company expects its full fiscal 2021 revenue to be between US$81 billion and US$82 billion, an increase of 94% YoY at the midpoint.

Also Read: Why is Pasithea Therapeutics (KTTA) stock rising today?

Abbott Laboratories (NYSE: ABT)

Abbott Laboratories is a medical instrument and healthcare firm based in Chicago, Illinois. It manufactures various healthcare products.

The stock was priced at US$139.41 at 3:10 pm ET on Dec 23, up 0.30% from its previous close. The ABT stock jumped 27.39% YTD.

Its market cap is US$246.46 billion, the P/E ratio is 34.59, and the forward P/E one year is 27.52. Its EPS is US$4.03. The stock saw the highest price of US$139.27 and the lowest price of US$105.36 in the last 52 weeks. Its share volume on Dec 22 was 6,768,868.

The company's sales rose 23.4% YoY to US$10.9 billion in Q3, FY21. Its net earnings came in at US$2.10 billion, compared to US$1.23 billion in Q3, FY20.

Also Read: Pfizer gets FDA greenlight for first Covid-19 pill Paxlovid

 Healthcare stocks: UNH, NVO, PFE, ABT, DHR

Also Read: Top stocks under US$1,000 to explore in 2022

Danaher Corporation (NYSE: DHR)

Danaher Corporation is a diversified multinational company based in Washington, D.C. It specializes in professional medical industrial and commercial products.

The shares of the company traded at US$322.11 at 3:15 pm ET on Dec 23, up 0.76% from their previous close. Its stock value soared 43.21% YTD.

The firm has a market cap of US$230.02 billion, a P/E ratio of 40.8, and a forward P/E one year of 32.45. Its EPS is US$7.89. The 52-week highest and lowest stock prices were US$333.96 and US$211.22, respectively. Its trading volume was 2,190,639 on Dec 22.

The revenue increased by 23% YoY to US$7.2 billion in Q3, FY21. Its net income came in at US$1.15 billion, compared to US$883 million in the same quarter of the previous year.

Also Read: Yearender: Consumer stocks that created a buzz in 2021

Bottomline

The healthcare sector saw rapid growth in recent quarters. For instance, the S&P 500 healthcare sector jumped 22.28% YTD while increasing 9.10% QTD. However, investors should closely evaluate the companies before investing in stocks.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.

Featured Articles